There were 2,436 press releases posted in the last 24 hours and 441,499 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
I-Mab and MorphoSys Announce First Patient Dosed in Phase 3 Clinical Trial of TJ202/MOR202 in r/r Multiple Myeloma in Mainland China

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image